Klow

KLOW is an advanced, quad-compound synthetic peptide matrix combining GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg). This synergistic research formulation targets complex cellular regeneration, tissue remodeling, and systemic inflammatory modulation. The combination leverages the copper-peptide GHK-Cu for extracellular matrix support, alongside BPC-157 and TB-500 for accelerated cell migration and angiogenesis. Fortified with KPV for targeted inflammatory regulation, KLOW is classified as a comprehensive regenerative peptide blend for research applications investigating advanced tissue recovery, inflammatory pathways, and cellular homeostasis.